The challenge
A US biotech company was running its most complex clinical trial to date.
While they had previously relied on an in-house team of medical writers to produce clinical and regulatory documents, they soon realized that the Phase 2 Clinical Study Report (CSR) needed for the program to progress was out of the scope of the in-house team’s experience and capabilities.
Enjoy the freedom to choose
We built a bespoke medical writing team to take on the CSR. Two expert Medical Writers completed the drafting and QC, supported by a dedicated project management team.
Each member had extensive experience in the therapeutic area and delivering complex CSRs for biotechs.
The biotech benefited from:
Experience and leadership
The Medical Writer who led this project provided strategic guidance throughout the process based on 20+ years’ experience.
Their level of attention to detail meant that inconsistencies and potential issues in the report were identified and corrected before submission to avoid unnecessary delays.
The writer’s approach and ability to integrate seamlessly into the client’s team helped build trust and ensure smooth collaboration throughout the project.
High-quality delivery
The client’s study was highly intricate, involving many exploratory endpoints, blinded and open-label phases, multiple patient cohorts and regimens, extensive pharmacokinetics, and post-hoc analyses. The assigned Medical Writer’s dual knowledge of therapeutic content and regulatory documentation was essential in managing the study’s complexity and ensuring the delivery of a high-quality, compliant document.
Project Management
Our dedicated project management team supported the project by coordinating reviews and adapting flexibly to shifting timelines. They used project planning tools to map out the project and track progress, as well as AI tools to facilitate meetings and minimize the risk of key points being overlooked.
Robust Processes
Open communication and strategic meetings ensured everyone was aligned on expectations, objectives and responsibilities from the start of the project. Proven processes and clearly mapped timelines ensured the client felt confident that their CSR would be delivered on time and to a high standard.
The impact
The assigned Medical Writer’s technical expertise, combined with the efficiency of our hybrid model, meant that the client’s incredibly complex CSR was delivered on time and under budget.
The quality of the final deliverable detailing multiple exploratory endpoints has allowed this program to form the foundation for the additional drug development programs in the client’s pipeline.
Feel confident in your clinical and regulatory documents
Get in touch to discuss how our experienced team and Medical Writers can support you.
Our work
Advancing Cell and Gene Therapy
Morula Health delivered rapid Clinical Study Report development for a US biotech advancing a cell and gene therapy program. Our specialist writers ensured regulatory‑ready documentation while meeting accelerated timelines.
Find out more
Breaking Barriers: Facilitating FDA Approval
Morula Health developed a first‑in‑human Phase 1 protocol for an FDA IND submission within five weeks. By combining regulatory insight with immuno‑oncology expertise, our team helped the client meet critical timelines and advance their program toward approval.
Find out more
Long-term FSP Partnership Facilitates Expansion from China to the US
Through a long‑term FSP partnership, Morula Health supported a Chinese biotech expanding into the US market. Our regulatory and clinical medical writing expertise enabled IND readiness and supported alignment with FDA expectations.
Find out more